JAC Advance Access originally published online on January 5, 2006
Journal of Antimicrobial Chemotherapy 2006 57(3):424-429; doi:10.1093/jac/dki478
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Distribution of a transposon-like element carrying blaCMY-2 among Salmonella and other Enterobacteriaceae
1 Department of Clinical Pathology, Chang Gung Memorial Hospital, 5 Fu-Hsin Street, Kweishan, Taoyuan 333, Taiwan; 2 Department of Medical Biotechnology and Laboratory Science, Chang Gung University, 259 Wenhua 1st Road, Kweishan, Taoyuan 333, Taiwan; 3 Department of Medicine, Chang Gung University, 259 Wenhua 1st Road, Kweishan, Taoyuan 333, Taiwan; 4 Department of Pediatrics, Chang Gung Children's Hospital, 5 Fu-Hsin Street, Kweishan, Taoyuan 333, Taiwan; 5 Department of Molecular Biotechnology, Da-Yeh University, 112 Shan-Jiau Road, Da-Tsuen, Changhua 515, Taiwan; 6 Department of Applied Microbiology, National Chiayi University, 300 University Road, Chiayi 600, Taiwan
* Corresponding author. Tel: +886-3-3281200 ext. 8896; Fax: +886-3-3288957; E-mail: chchiu{at}adm.cgmh.org.tw
Received 29 August 2005; returned 25 September 2005; revised 16 November 2005; accepted 12 December 2005
| Abstract |
|---|
|
|
|---|
Objectives: The dissemination of cephamycin resistance in Enterobacteriaceae and its correlation with a transposon-like DNA element consisting of a specific tnpA-blaCMY-2-blc-sugE structure were investigated.
Methods: A total of 140 enterobacterial isolates belonging to 17 species (10 genera) of Enterobacteriaceae phenotypically characterized as putative AmpC-producers were evaluated. The isolates were examined by PCR analysis, DNADNA hybridization and nucleotide sequencing.
Results: The blaCMY-2-carrying element was detected in 34 isolates from 10 species (9 genera), including all 14 Salmonella and 4 Shigella isolates as well as 7 of the 10 Escherichia coli isolates tested. The remaining 9 isolates were from 112 isolates of the other 14 species tested. The genetic structure of the blaCMY-2-carrying element was identical in 29 isolates, while in 3 E. coli and 2 Citrobacter isolates an additional insertion sequence IS1 was found inserted at various nucleotide positions close to the 3' end, either within or downstream, of tnpA. In 12 of the 14 representative isolates examined, the blaCMY-2-carrying element was found inserted in the finQ gene of various-sized plasmids with highly conserved 8 bp direct repeats flanking the junction regions. Among the other 106 non-CMY-2-producing isolates, plasmid-mediated ampC genes were found only in one isolate of Enterobacter aerogenes which carried a blaDHA-1-like gene.
Conclusions: blaCMY-2 is the most prevalent plasmid-mediated ampC gene among Enterobacteriaceae. All the blaCMY-2 genes identified in the present study were associated with a specific transposon-like element that may be responsible for the spread of blaCMY-2 among Enterobacteriaceae.
Keywords: plasmid-mediated AmpC ß-lactamases , cephamycin resistance , DHA-1-like ß-lactamases
| Introduction |
|---|
|
|
|---|
Among Gram-negative bacteria, the emergence of resistance to extended-spectrum cephalosporins has constituted a global problem. Production of AmpC ß-lactamases is one of the major mechanisms leading to such resistance. These ß-lactamases are of great concern since they not only confer resistance to 7-
-methoxy-cephalosporins but also are not inhibited by commercially available ß-lactamase inhibitors.1 Genes encoding AmpC ß-lactamases were originally located on the chromosome of many Enterobacteriaceae and other Gram-negative bacteria.2 In 1989, Bauernfeind et al.3 first described that the resistance of a Klebsiella pneumoniae isolate to cefoxitin, cefotetan, oxyimino-cephalosporins, and monobactams could be transferred to Escherichia coli. The ß-lactamase detected was termed CMY-1 for its cephamycinase activity.3 Subsequently, such plasmid-mediated AmpC ß-lactamases were discovered widely in many bacterial species not naturally producing AmpC.1 These plasmid-mediated enzymes have recently been classified into six genetic clusters,4 in which CMY-2 is the most prevalent and has been found in many areas of the world.1 In the United States, plasmid-mediated CMY-2 has been found in clinical isolates of Salmonella,5,6 thereby posing a serious threat to public health. Several Salmonella serotypes have been involved, such as Salmonella Typhimurium, Salmonella Choleraesuis, Salmonella Cremieu, Salmonella Enteritidis, Salmonella Gloucester, Salmonella Hadar, Salmonella Kimuenza, Salmonella Mons, Salmonella Newport, Salmonella Redba, Salmonella Schleissheim and Salmonella Senftenberg.511 We recently isolated a strain of Salmonella Choleraesuis, SC-B67, which was resistant to ceftriaxone and ciprofloxacin from a patient with sepsis.12 The resistance to ceftriaxone was attributed to the presence of a plasmid-mediated blaCMY-2 gene.12,13 Analysis of the genetic structure of the blaCMY-2 gene in SC-B67 showed that it was located on a transposon-like DNA element consisting of a specific tnpA-blaCMY-2-blc-sugE structure.12 To explore the extent to which the blaCMY-2-carrying element may have contributed to the cephamycin resistance among Enterobacteriaceae, putative AmpC-producers were collected from a wide spectrum of enterobacterial species with phenotypic methods and subjected to molecular investigations.
| Materials and methods |
|---|
|
|
|---|
Bacterial isolates
Bacterial isolates belonging to the family Enterobacteriaceae were collected during 20022003 from clinical specimens of patients treated at Chang Gung Memorial Hospital and Children's Hospital, Taoyuan, Taiwan, using standard methods.14 Isolates showing resistance to cefoxitin in a disc test were considered as putative AmpC-producers and subjected to further molecular studies. After being genotyped by a previously described method, infrequent-restriction-site PCR,15 only isolates of different genotypes were included in the study. A maximum of 10 isolates of each species were selected except that all Salmonella isolates were included in the study due to their rarity.
Detection of the transposon-like blaCMY-2-carrying DNA element
Extraction of bacterial DNA was performed using a DNeasy Tissue Kit (QIAGEN GmbH, Hilden, Germany), according to the instructions of the manufacturer. For the analysis of genetic arrangement of the resistance genes, overlapping PCR amplification of internal regions of the transposon-like element that carried blaCMY-2 was performed.12 The associated primers used are listed in Table 1. As shown in Figure 1, Tn-F/AmpC-R, AmpC-F/SugE-R, AmpC-F/AmpC-R and Tn-F/SugE-R were used as paired primers to amplify various regions of the DNA element and the expected molecular sizes of the PCR products were 2930, 2583, 1646 and 3867 bp, respectively. Salmonella Choleraesuis SC-B67 that carried the specific DNA element containing the blaCMY-2 gene was used as a positive control in each experiment.12
|
|
Isolates with PCR products of the same sizes as those expected were considered as having the same specific DNA element as SC-B67 and no further sequence analysis were performed, except that all amplicons produced by the primer pair AmpC-F/AmpC-R were sequenced to specify the associated ampC genes. Such PCR products and those with sizes different from the expected were purified using the Microcon® PCR Centrifugal Filter Devices (Millipore Corporation, Bedford, MA, USA) and sequenced by using the ABI 3100-Avant Genetic Analyzer (Perkin-Elmer, Applied Biosystems, Foster City, CA, USA). The nucleotide sequences obtained were compiled and analysed using the Lasergene software (DNASTAR, Inc., Madison, WI, USA). The search for homologous sequences was conducted in the GenBank database using the Basic Local Alignment Search Tool (BLAST) through the Internet (http://www.ncbi.nlm.nih.gov/BLAST/).
Detection of other plasmid-mediated ampC genes by using a multiplex PCR and DNA sequence analysis
Because the primers used in the above screening were purposely designed to identify the presence of the specific structure containing the blaCMY-2-carrying DNA element, CMY-2-producing isolates that do not harbour the specific structure may not be amplified. Thus isolates negative in the above screening were further examined by using a multiplex PCR4 previously developed for the detection of family-specific plasmid-mediated ampC genes. The multiplex PCR was shown to amplify the majority of the six genetic groups of currently known plasmid-mediated ampC genes, including blaCMY-2.4 PCR-sequencing was further performed for any isolates positive in the multiplex PCR using respective primers described previously16 or those listed in Table 1.
Plasmid analysis and DNADNA hybridization
The presence of plasmids was checked using a modified alkaline lysis method as described previously.17 DNADNA hybridization was performed by using the method of Southern,18 except that the probe for the target CMY-2 ß-lactamase gene was prepared and labelled with digoxigenin-11-deoxyuridine triphosphate (Roche, Molecular Biochemicals, Mannheim, Germany).
DNA sequence analysis of the flanking regions of blaCMY-2
To reveal the insertion site of the specific blaCMY-2-containing DNA element among different organisms, the plasmid DNA of representative strains was extracted using a QIAGEN Plasmid Kit (QIAGEN GmbH, Hilden, Germany) and sequenced using the procedure described above. Two primers, Tn-R and SugE-F (Table 1), were used for the sequence analysis of junction regions between the plasmid sequence and tnpA on the 5' end and sugE and the plasmid sequence on the 3' end, respectively.
| Results |
|---|
|
|
|---|
A total of 140 Gram-negative bacterial isolates belonging to 17 species (10 genera) of the family Enterobacteriaceae were evaluated in this study (Table 2). The blaCMY-2-carrying transposon-like element was detected in 34 isolates from 10 species (9 genera), including all 14 Salmonella and 4 Shigella isolates as well as 7 of the 10 E. coli isolates tested. In contrast, only 9 of the remaining 112 isolates from the other 14 species tested had the specific element (Table 2).
|
The genetic structure of the blaCMY-2-carrying element was identical to that of Salmonella Choleraesuis SC-B6712 in 29 of the 34 isolates. However, a minor genetic diversity of the DNA element was found in the remaining 5 isolates (Citrobacter diversus #204; Citrobacter amalonaticus #638; and E. coli #71, #910 and #929). The tnpA sequences were exactly the same among the 5 isolates as well as the other 12 isolates described below (Table 3). However, an additional insertion sequence IS1, 768 bp in length, was found at the 3' end of tnpA in the C. diversus and the 3 E. coli isolates, while a 754 bp IS1 was found inserted between tnpA and blaCMY-2 in the C. amalonaticus isolate. The exact nucleotide positions where the IS1 inserted in the blaCMY-2-containing element and the sequences of the respective flanking direct repeats are listed in Figure 1. In two of the E. coli isolates (#910 and #929) the IS1 was found inserted at the same nucleotide positions and thus had identical flanking direct repeats. In the remaining E. coli isolate (#71), the IS1 was found inserted at a different nucleotide position but was the same as that found in the C. diversus isolate (#204). Plasmid analysis and DNADNA hybridization indicated that the blaCMY-2-carrying transposon-like element was located on large plasmids of sizes ranging between 90 and 140 kb (data not shown).
|
Furthermore, sequences of the plasmid DNA flanking the blaCMY-2-carrying element were analysed in a total of 14 representative isolates (Table 3). Similar to what has been reported in the AmpC-producing Salmonella Choleraesuis SC-B67,12 the transposon-like element that carries blaCMY-2 was found inserted in the finQ gene of the transfer region of IncI1 plasmid ColIb-P919 in 12 of the 14 isolates tested, including E. coli #71 and C. amalonaticus #638, which had the additional IS1 at the end of tnpA. Only the Enterobacter cloacae and Salmonella Infantis isolates had different gene sequences flanking the blaCMY-2-containing transposon-like element (Table 3). The 8 bp direct repeats at junction regions surrounding the element were highly conserved in these isolates; only the two isolates with different flanking sequences had no such specific repeats (Table 3).
On the other hand, the blaCMY-2-carrying element was not identified in a total of 106 isolates, in which only one isolate of Enterobacter aerogenes was found to carry a blaDHA-1-like gene, by using the multiplex PCR for plasmid-mediated ampC genes. This DHA-1-like ß-lactamase had an identical amino acid sequence to that of DHA-1 except that one mutation occurred at amino acid position 29, where an alanine (GCG) was substituted by a valine (GTG).
| Discussion |
|---|
|
|
|---|
CMY-2 ß-lactamase is the most prevalent type of the plasmid-mediated AmpC enzymes and is distributed in a wide geographical area, having been reported in France, Greece, Turkey, the United Kingdom and the United States.3 In Taiwan, spread of blaCMY-2-carrying plasmids among Salmonella and E. coli isolates in both hospital and community settings have been frequently reported.10,16,20,21 The first report of plasmid-mediated CMY-2-type AmpC ß-lactamase identified among Shigella sonnei was also reported recently in Taiwan.22 In the present study, we confirmed that CMY-2 ß-lactamase is the most prevalent AmpC enzyme in the Enterobacteriaceae family and that all the blaCMY-2 genes were also bracketed by a specific transposon-like DNA element. As shown in Table 2, the blaCMY-2-carrying transposon-like element is widely distributed among 10 of the 17 species of the Enterobacteriaceae tested, notably in AmpC-producing Salmonella (14/14), Shigella (4/4) and E. coli (7/10). Clinical isolates of other species, such as E. cloacae (1/10), C. diversus (2/10), Morganella morganii (1/10), Proteus rettgeri (1/4) and Providencia stuartii (1/10), although known as natural inducible AmpC-producers,1 also carried this blaCMY-2-containing DNA element at a lower rate. To our knowledge, this is the first report of the presence of blaCMY-2 among these bacterial species. These results raised a speculation that the spread of blaCMY-2 occurred through lateral gene transfer among these bacterial species.
In contrast to the wide spread of CMY-2-producing isolates among Enterobacteriaceae, a much lower prevalence of the other plasmid-mediated ampC genes was noted in the present study. Similar situations were found in previous studies from Taiwan where only CMY-8 and DHA-1 have been sporadically reported in K. pneumoniae.23,24 E. aerogenes has been shown to carry a blaLAT-2-containing plasmid.25 The finding in the present study of a blaDHA-1-like gene, which was probably originated from M. morganii,7 in an isolate of E. aerogenes has never been reported before.
Antibiotic resistance can be disseminated throughout populations by epidemic spread of a particular clone or through the exchange of genetic materials. In the present study, the studied isolates were all of different genotypes, but all the isolates that produced AmpC-type ß-lactamases harboured the specific four-gene segment on their plasmids, suggesting that the dissemination of the resistance gene may be through plasmid transfer.
Genes for the AmpC-type ß-lactamases have been reported to be located on plasmids of sizes varying from 7 to 180 kb.1 A few of the plasmids are not self-transmissible but are transferred by transformation26 or mobilization.25,27 Winokur et al., in an earlier study, found that all cephalosporin-resistant Salmonella encoded a CMY-2-type ß-lactamase, and furthermore the resistance gene appeared to be located on large non-conjugative plasmids.26 Conjugation experiments were also performed to determine whether cephalosporin resistance could be transferred from our Salmonella isolates to E. coli DH5
. Despite multiple attempts, resistance could not be transferred by conjugation to the recipient E. coli strain using ceftriaxone and lactose utilization (MacConkey agar) as selection markers (C. H. Chiu, unpublished data). In this study, the DNA sequences surrounding the blaCMY-2-carrying element were examined and in the majority of the Enterobacteriaceae tested this element was found inserted in the finQ gene of IncI1 large plasmids, as evidenced by the identification of an 8 bp direct repeat at both junction regions. Although the plasmids that carried this element appeared non-conjugative, our previous study has proved that the plasmid of Salmonella Choleraesuis SC-B67 contains an oriT sequence and a defective tra gene system,13 indicating that these plasmids may be mobilizable.28,29
A Citrobacter freundii-type blaCMY-5 gene has been mapped in the Klebsiella oxytoca plasmid pTKH11 to be adjacent to the blc and sugE genes found downstream of ampC on the C. freundii chromosome.30 The ampR gene upstream of ampC on the chromosome is lost and its place has been taken by a putative insertion element, which could have been involved in gene capture. In the present study, DNA structures surrounding the blaCMY-2 had a similar organization among the clinical isolates of the Enterobacteriaceae checked, suggesting that the resistance determinants were derived directly from the C. freundii chromosome. The finding in five isolates of one additional IS1 inserted close to the end of the tnpA may represent a recent evolution. Furthermore, although plasmids carrying the specific blaCMY-2-containing element were not identical, the conserved genetic organization of the blaCMY-2-carrying element and the surrounding DNA sequence among the isolates studied suggests that the whole segment, including the surrounding DNA sequence, might have been transferred altogether on a plasmid to other bacteria of the same or different species.
In conclusion, results of this work suggested that blaCMY-2 is spread among members of the Enterobacteriaceae family primarily through the transfer, probably by mobilization, of various plasmids carrying the specific transposon-like DNA element. The efficiency of plasmid transfer by mobilization is generally lower than that by conjugation;29 therefore, one could predict that the inter-species spread of the plasmid-mediated resistance would be slow. Nevertheless, the continuous spread of CMY-2-producing organisms appears unavoidable and plasmid DNA can evolve rapidly over time.31 Further study on the transfer mechanism of the blaCMY-2 gene among Enterobacteriaceae is warranted.
| Transparency declarations |
|---|
|
|
|---|
None to declare.
| Acknowledgements |
|---|
This work was supported by grants NSC93-2314-B-182A-071 and NSC94-2321-B-182A-003 from National Science Council, Executive Yen, Taiwan, and CMRPG63011 from Chang Gung Memorial Hospital, Taiwan.
| References |
|---|
|
|
|---|
1. Philippon A, Arlet G, Jacoby G. Plasmid-determined AmpC-type ß-lactamases. Antimicrob Agents Chemother 2002; 46: 111.
2.
Barlow M, Hall BG. Origin and evolution of the AmpC ß-lactamases of Citrobacter freundii. Antimicrob Agents Chemother 2002; 46: 11908.
3. Bauernfeind A, Chong Y, Schweighart S. Extended broad spectrum ß-lactamase in Klebsiella pneumoniae including resistance to cephamycins. Infection 1989; 17: 31621.[CrossRef][Web of Science][Medline]
4.
Pérez-Pérez FJ, Hanson ND. Detection of plasmid-mediated AmpC ß-lactamase genes in clinical isolates by using multiple PCR. J Clin Microbiol 2002; 40: 215362.
5.
Dunne EF, Fey PD, Kludt P et al. Emergence of domestically acquired ceftriaxone-resistant Salmonella infections associated with AmpC ß-lactamase. JAMA 2000; 284: 31516.
6. Fey PD, Safranek TJ, Rupp ME et al. Ceftriaxone-resistant salmonella infection acquired by a child from cattle. N Engl J Med 2002; 342: 12429.
7.
Barnaud G, Arlet G, Verdet C et al. Salmonella enteritidis: AmpC plasmid-mediated inducible ß-lactamase (DHA-1) with an ampR gene from Morganella morganii. Antimicrob Agents Chemother 1998; 42: 23528.
8. Koeck JL, Arlet G, Philippon A et al. A plasmid-mediated CMY-2 ß-lactamase from an Algerian clinical isolate of Salmonella senftenberg. FEMS Microbiol Lett 1997; 152: 25560.[Web of Science][Medline]
9. Poppe C, Martin LC, Gyles CL et al. Acquisition of resistance to extended-spectrum cephalosporins by Salmonella enterica subsp. enterica serovar Newport and Escherichia coli in the turkey poult intestinal tract. J Clin Microbiol 2005; 71: 118492.
10.
Su LH, Wu TL, Chia JH et al. Increasing ceftriaxone resistance in Salmonella isolates from a university hospital in Taiwan. J Antimicrob Chemother 2005; 55: 84652.
11. Yan JJ, Chiu CH, Ko WC et al. Ceftriaxone-resistant Salmonella enterica serovar Hadar: evidence for interspecies transfer of blaCMY-2 in a Taiwanese university hospital. J Formos Med Assoc 2002; 101: 6658.[Web of Science][Medline]
12. Chiu CH, Su LH, Chu C et al. Isolation of Salmonella enterica serotype choleraesuis resistant to ceftriaxone and ciprofloxacin. Lancet 2004; 363: 12856.[CrossRef][Web of Science][Medline]
13.
Chiu CH, Tang P, Chu C et al. The genome sequence of Salmonella enterica serovar Choleraesuis, a highly invasive and resistant zoonotic pathogen. Nucleic Acids Res 2005; 33: 16908.
14. Farmer JJ III. Enterobacteriaceae: introduction and identification. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of Clinical Microbiology, sixth edition. Washington DC: American Society for Microbiology, 1995; 43849.
15. Su LH, Leu HS, Chiu YP et al. Molecular investigation of two clusters of nosocomial bacteraemia caused by multiresistant Klebsiella pneumoniae using pulsed-field gel electrophoresis and infrequent-restriction-site PCR. J Hosp Infect 2000; 46: 1107.[CrossRef][Web of Science][Medline]
16.
Yan JJ, Ko WC, Tsai SH et al. Dissemination of CTX-M-3 and CMY-2 ß-lactamases among clinical isolates of Escherichia coli in southern Taiwan. J Clin Microbiol 2000; 38: 43205.
17.
Kado CI, Liu ST. Rapid procedure for detection and isolation of large and small plasmids. J Bacteriol 1981; 145: 136573.
18. Southern EM. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 1975; 98: 50317.[CrossRef][Web of Science][Medline]
19.
Hama C, Takizawa T, Moriwaki H et al. Organization of the replication control region of plasmid ColIb-P9. J Bacteriol 1990; 172: 198391.
20. Yan JJ, Ko WC, Chiu CH et al. Emergence of ceftriaxone-resistant Salmonella isolates and rapid spread of plasmid-encoded CMY-2-like cephalosporinase, Taiwan. Emerg Infect Dis 2003; 9: 3238.[Web of Science][Medline]
21.
Yan JJ, Hong CY, Ko WC et al. Dissemination of blaCMY-2 among Escherichia coli isolates from food animals, retail ground meats, and humans in southern Taiwan. Antimicrob Agents Chemother 2004; 48: 13536.
22.
Huang IF, Chiu CH, Wang MH et al. Outbreak of dysentery associated with ceftriaxone-resistant Shigella sonnei: First report of plasmid-mediated CMY-2-type AmpC ß-lactamase resistance in Shigella sonnei. J Clin Microbiol 2005; 43: 260812.
23.
Yan JJ, Wu SM, Tsai SH et al. Prevalence of SHV-12 among clinical isolates of Klebsiella pneumoniae producing extended-spectrum ß-lactamases and identification of a novel AmpC enzyme (CMY-8) in Southern Taiwan. Antimicrob Agents Chemother 2000; 44: 143842.
24.
Yan JJ, Ko WC, Ko WC et al. Emergence of Klebsiella pneumoniae isolates producing inducible DHA-1 ß-lactamase in a university hospital in Taiwan. J Clin Microbiol 2002; 40: 31216.
25. Gazouli M, Tzouvelekis LS, Prinarakis E et al. Transferable cefoxitin resistance in enterobacteria from Greek hospitals and characterization of a plasmid-mediated group 1 ß-lactamase (LAT-2). Antimicrob Agents Chemother 1996; 40: 173640.[Abstract]
26.
Winokur PL, Brueggemann A, DeSalvo DL et al. Animal and human multidrug-resistance, cephalosporin-resistasnt Salmonella isolates expressing a plasmid-mediated CMY-2 AmpC ß-lactamase. Antimicrob Agents Chemother 2000; 44: 277783.
27.
Tzouvelekis LS, Tzelepi E, Mentis AF et al. Identification of a novel plasmid-mediated ß-lactamase with chromosomal cephalosporinase characteristics from Klebsiella pneumoniae. J Antimicrob Chemother 1993; 31: 64554.
28. Ou JT, Lin MY, Chao HL. Presence of F-like OriT base-pair sequence on the virulence plasmids of Salmonella serovars Gallinarum, Enteritidis, and Typhimurium, but absent in those of Choleraesuis and Dublin. Microb Pathog 1994; 17: 1321.[CrossRef][Web of Science][Medline]
29.
Chu C, Chiu CH, Chu CH et al. Nucelotide and amino acid sequences of oriT-traM-traJ-traY-traA-traL regions and mobilization of virulence plasmids of Salmonella enterica serovars Enteritidis, Gallinarum-Pullorum, and Typhimurium. J Bacteriol 2002; 184: 285762.
30.
Wu SW, Dornbusch K, Kronvall G et al. Characterization and nucleotide sequence of a Klebsiella oxytoca cryptic plasmid encoding a CMY-type ß-lactamase: confirmation that the plasmid-mediated cephamycinase originated from the Citrobacter freundii AmpC ß-lactamase. Antimicrob Agents Chemother 1999; 43: 13507.
31.
Kron MA, Shlaes DM, Currie-McCumber C et al. Molecular epidemiology of OHIO-1 ß-lactamase. Antimicrob Agents Chemother 1987; 31: 20079.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
R. Gonzalez-Sanz, S. Herrera-Leon, M. de la Fuente, M. Arroyo, and M. A. Echeita Emergence of extended-spectrum {beta}-lactamases and AmpC-type {beta}-lactamases in human Salmonella isolated in Spain from 2001 to 2005 J. Antimicrob. Chemother., December 1, 2009; 64(6): 1181 - 1186. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. F. Fricke, P. F. McDermott, M. K. Mammel, S. Zhao, T. J. Johnson, D. A. Rasko, P. J. Fedorka-Cray, A. Pedroso, J. M. Whichard, J. E. LeClerc, et al. Antimicrobial Resistance-Conferring Plasmids with Similarity to Virulence Plasmids from Avian Pathogenic Escherichia coli Strains in Salmonella enterica Serovar Kentucky Isolates from Poultry Appl. Envir. Microbiol., September 15, 2009; 75(18): 5963 - 5971. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Verdet, V. Gautier, E. Chachaty, E. Ronco, N. Hidri, D. Decre, and G. Arlet Genetic Context of Plasmid-Carried blaCMY-2-Like Genes in Enterobacteriaceae Antimicrob. Agents Chemother., September 1, 2009; 53(9): 4002 - 4006. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. F. Mataseje, N. Neumann, B. Crago, P. Baudry, G. G. Zhanel, M. Louie, M. R. Mulvey, and and the ARO Water Study Group Characterization of Cefoxitin-Resistant Escherichia coli Isolates from Recreational Beaches and Private Drinking Water in Canada between 2004 and 2006 Antimicrob. Agents Chemother., July 1, 2009; 53(7): 3126 - 3130. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Zioga, J. M. Whichard, S. D. Kotsakis, L. S. Tzouvelekis, E. Tzelepi, and V. Miriagou CMY-31 and CMY-36 Cephalosporinases Encoded by ColE1-Like Plasmids Antimicrob. Agents Chemother., March 1, 2009; 53(3): 1256 - 1259. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Haldorsen, B. Aasnaes, K. H. Dahl, A.-M. Hanssen, G. S. Simonsen, T. R. Walsh, A. Sundsfjord, and E. W. Lundblad The AmpC phenotype in Norwegian clinical isolates of Escherichia coli is associated with an acquired ISEcp1-like ampC element or hyperproduction of the endogenous AmpC J. Antimicrob. Chemother., October 1, 2008; 62(4): 694 - 702. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. McIntosh, M. Cunningham, B. Ji, F. A. Fekete, E. M. Parry, S. E. Clark, Z. B. Zalinger, I. C. Gilg, G. R. Danner, K. A. Johnson, et al. Transferable, multiple antibiotic and mercury resistance in Atlantic Canadian isolates of Aeromonas salmonicida subsp. salmonicida is associated with carriage of an IncA/C plasmid similar to the Salmonella enterica plasmid pSN254 J. Antimicrob. Chemother., June 1, 2008; 61(6): 1221 - 1228. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Mammeri, F. Eb, A. Berkani, and P. Nordmann Molecular characterization of AmpC-producing Escherichia coli clinical isolates recovered in a French hospital J. Antimicrob. Chemother., March 1, 2008; 61(3): 498 - 503. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. E. Sidjabat, N. D. Hanson, E. Smith-Moland, J. M. Bell, J. S. Gibson, L. J. Filippich, and D. J. Trott Identification of plasmid-mediated extended-spectrum and AmpC {beta}-lactamases in Enterobacter spp. isolated from dogs J. Med. Microbiol., March 1, 2007; 56(3): 426 - 434. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||




